301 related articles for article (PubMed ID: 31247632)
1. Hepatocellular carcinoma recurrence after liver transplantation in a Brazilian multicenter study: clinical profile and prognostic factors of survival.
Chagas AL; Felga GEG; Diniz MA; Silva RF; Mattos AA; Silva RCMA; Boin IFSF; Garcia JHP; Lima AS; Coelho JCU; Bittencourt PL; Alves VAF; D'Albuquerque LAC; Carrilho FJ;
Eur J Gastroenterol Hepatol; 2019 Sep; 31(9):1148-1156. PubMed ID: 31247632
[TBL] [Abstract][Full Text] [Related]
2. Recurrence of hepatocellular carcinoma after liver transplantation: Is there a place for resection?
Fernandez-Sevilla E; Allard MA; Selten J; Golse N; Vibert E; Sa Cunha A; Cherqui D; Castaing D; Adam R
Liver Transpl; 2017 Apr; 23(4):440-447. PubMed ID: 28187493
[TBL] [Abstract][Full Text] [Related]
3. A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients.
Agopian VG; Harlander-Locke M; Zarrinpar A; Kaldas FM; Farmer DG; Yersiz H; Finn RS; Tong M; Hiatt JR; Busuttil RW
J Am Coll Surg; 2015 Apr; 220(4):416-27. PubMed ID: 25690672
[TBL] [Abstract][Full Text] [Related]
4. Propensity-Matched Analysis of Patients with Mixed Hepatocellular-Cholangiocarcinoma and Hepatocellular Carcinoma Undergoing Liver Transplantation.
Lunsford KE; Court C; Seok Lee Y; Lu DS; Naini BV; Harlander-Locke MP; Busuttil RW; Agopian VG
Liver Transpl; 2018 Oct; 24(10):1384-1397. PubMed ID: 29573187
[TBL] [Abstract][Full Text] [Related]
5. Benefit of Treating Hepatocellular Carcinoma Recurrence after Liver Transplantation and Analysis of Prognostic Factors for Survival in a Large Euro-American Series.
Sapisochin G; Goldaracena N; Astete S; Laurence JM; Davidson D; Rafael E; Castells L; Sandroussi C; Bilbao I; Dopazo C; Grant DR; Lázaro JL; Caralt M; Ghanekar A; McGilvray ID; Lilly L; Cattral MS; Selzner M; Charco R; Greig PD
Ann Surg Oncol; 2015 Jul; 22(7):2286-94. PubMed ID: 25472651
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors in patients with recurrent hepatocellular carcinoma treated with salvage liver transplantation: a single-center study.
Wang P; Li H; Shi B; Que W; Wang C; Fan J; Peng Z; Zhong L
Oncotarget; 2016 Jun; 7(23):35071-83. PubMed ID: 27145461
[TBL] [Abstract][Full Text] [Related]
7. Predictive factors for extrahepatic recurrence of hepatocellular carcinoma following liver transplantation.
Andreou A; Bahra M; Schmelzle M; Öllinger R; Sucher R; Sauer IM; Guel-Klein S; Struecker B; Eurich D; Klein F; Pascher A; Pratschke J; Seehofer D
Clin Transplant; 2016 Jul; 30(7):819-27. PubMed ID: 27107252
[TBL] [Abstract][Full Text] [Related]
8. Impact of Brazilian expanded criteria for liver transplantation in patients with hepatocellular carcinoma: a multicenter study.
Chagas AL; Mattos AA; Diniz MA; Felga GEG; Boin IFSF; Silva RCMA; Silva RF; Garcia JHP; Lima AS; Coelho JCU; Bittencourt PL; Alves VAF; D'Albuquerque LAC; Carrilho FJ;
Ann Hepatol; 2021; 22():100294. PubMed ID: 33276136
[TBL] [Abstract][Full Text] [Related]
9. Time of hepatocellular carcinoma recurrence after liver resection and alpha-fetoprotein are important prognostic factors for salvage liver transplantation.
Lee S; Hyuck David Kwon C; Man Kim J; Joh JW; Woon Paik S; Kim BW; Wang HJ; Lee KW; Suh KS; Lee SK
Liver Transpl; 2014 Sep; 20(9):1057-63. PubMed ID: 24862741
[TBL] [Abstract][Full Text] [Related]
10. Outcome of liver transplantation for hepatocellular carcinoma -- a single center experience.
Iacob R; Iacob S; Gheorghe L; Gheorghe C; Hrehoreţ D; Brașoveanu V; Croitoru A; Herlea V; Popescu I
Chirurgia (Bucur); 2013; 108(4):446-50. PubMed ID: 23958083
[TBL] [Abstract][Full Text] [Related]
11. Serological Risk Index Based on Alpha-Fetoprotein and C-Reactive Protein to Indicate Futile Liver Transplantation Among Patients with Advanced Hepatocellular Carcinoma.
Kornberg A; Schernhammer M; Kornberg J; Friess H; Thrum K
Dig Dis Sci; 2019 Jan; 64(1):269-280. PubMed ID: 30259282
[TBL] [Abstract][Full Text] [Related]
12. Clinical Features and Surveillance of Very Late Hepatocellular Carcinoma Recurrence After Liver Transplantation.
Alshahrani AA; Ha SM; Hwang S; Ahn CS; Kim KH; Moon DB; Ha TY; Song GW; Jung DH; Park GC; Cho HD; Kwon JH; Kang SH; Lee SG
Ann Transplant; 2018 Sep; 23():659-665. PubMed ID: 30237389
[TBL] [Abstract][Full Text] [Related]
13. Post-transplant infection improves outcome of hepatocellular carcinoma patients after orthotopic liver transplantation.
Chao JS; Zhao SL; Ou-Yang SW; Qian YB; Liu AQ; Tang HM; Zhong L; Peng ZH; Xu JM; Sun HC
World J Gastroenterol; 2019 Oct; 25(37):5630-5640. PubMed ID: 31602163
[TBL] [Abstract][Full Text] [Related]
14. Follow-up Imaging After Liver Transplantation Should Take Into Consideration Primary Hepatocellular Carcinoma Characteristics.
Dioguardi Burgio M; Ronot M; Fuks D; Dondero F; Cauchy F; Gaujoux S; Dokmak S; Paradis V; Durand F; Belghiti J; Vilgrain V
Transplantation; 2015 Aug; 99(8):1613-8. PubMed ID: 25710611
[TBL] [Abstract][Full Text] [Related]
15. Identifying patients at higher risk of hepatocellular carcinoma recurrence after liver transplantation in a multicenter cohort study from Argentina.
Piñero F; Marciano S; Anders M; Orozco Ganem F; Zerega A; Cagliani J; Andriani O; de Santibañes E; Gil O; Podestá LG; McCormack L; Gadano A; Silva M
Eur J Gastroenterol Hepatol; 2016 Apr; 28(4):421-7. PubMed ID: 26684693
[TBL] [Abstract][Full Text] [Related]
16. Predictive value of nodule size and differentiation in HCC recurrence after liver transplantation.
Guerrini GP; Pinelli D; Di Benedetto F; Marini E; Corno V; Guizzetti M; Aluffi A; Zambelli M; Fagiuoli S; Lucà MG; Lucianetti A; Colledan M
Surg Oncol; 2016 Dec; 25(4):419-428. PubMed ID: 26403621
[TBL] [Abstract][Full Text] [Related]
17. Radiofrequency ablation of hepatocellular carcinoma as bridge therapy to liver transplantation: A 10-year intention-to-treat analysis.
Lee MW; Raman SS; Asvadi NH; Siripongsakun S; Hicks RM; Chen J; Worakitsitisatorn A; McWilliams J; Tong MJ; Finn RS; Agopian VG; Busuttil RW; Lu DSK
Hepatology; 2017 Jun; 65(6):1979-1990. PubMed ID: 28170115
[TBL] [Abstract][Full Text] [Related]
18. Ten-Year Outcomes of Liver Transplant and Downstaging for Hepatocellular Carcinoma.
Tabrizian P; Holzner ML; Mehta N; Halazun K; Agopian VG; Yao F; Busuttil RW; Roberts J; Emond JC; Samstein B; Brown RS; Najjar M; Chapman WC; Doyle MM; Florman SS; Schwartz ME; Llovet JM
JAMA Surg; 2022 Sep; 157(9):779-788. PubMed ID: 35857294
[TBL] [Abstract][Full Text] [Related]
19. Increased hepatocellular carcinoma recurrence in women compared to men with high alpha fetoprotein at liver transplant.
Sarkar M; Dodge JL; Roberts JP; Terrault N; Yao F; Mehta N
Ann Hepatol; 2016; 15(4):545-9. PubMed ID: 27236153
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for fatal recurrence of hepatocellular carcinoma and their role in selecting candidates for liver transplantation.
Zou WL; Zang YJ; Chen XG; Shen ZY
Hepatobiliary Pancreat Dis Int; 2008 Apr; 7(2):145-51. PubMed ID: 18397848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]